- Home
- EXPI vs ARQT Comparison
EXPI vs ARQT Comparison
Compare EXPI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXPI
- ARQT
- Stock Information
- Founded
- EXPI 2008
- ARQT 2016
- Country
- EXPI United States
- ARQT United States
- Employees
- EXPI N/A
- ARQT N/A
- Industry
- EXPI Real Estate
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- EXPI Finance
- ARQT Health Care
- Exchange
- EXPI Nasdaq
- ARQT Nasdaq
- Market Cap
- EXPI 1.8B
- ARQT 2.1B
- IPO Year
- EXPI N/A
- ARQT 2020
- Fundamental
- Price
- EXPI $10.78
- ARQT $21.48
- Analyst Decision
- EXPI Strong Buy
- ARQT Strong Buy
- Analyst Count
- EXPI 1
- ARQT 7
- Target Price
- EXPI $12.00
- ARQT $19.00
- AVG Volume (30 Days)
- EXPI 1.1M
- ARQT 1.9M
- Earning Date
- EXPI 11-06-2025
- ARQT 10-28-2025
- Dividend Yield
- EXPI 1.84%
- ARQT N/A
- EPS Growth
- EXPI N/A
- ARQT N/A
- EPS
- EXPI N/A
- ARQT N/A
- Revenue
- EXPI $4,593,157,000.00
- ARQT $263,464,999.00
- Revenue This Year
- EXPI $3.60
- ARQT $72.46
- Revenue Next Year
- EXPI $4.71
- ARQT $31.69
- P/E Ratio
- EXPI N/A
- ARQT N/A
- Revenue Growth
- EXPI 3.62
- ARQT 99.50
- 52 Week Low
- EXPI $6.90
- ARQT $8.03
- 52 Week High
- EXPI $15.22
- ARQT $21.30
- Technical
- Relative Strength Index (RSI)
- EXPI 47.41
- ARQT 68.27
- Support Level
- EXPI $10.46
- ARQT $19.41
- Resistance Level
- EXPI $11.11
- ARQT $20.89
- Average True Range (ATR)
- EXPI 0.40
- ARQT 0.99
- MACD
- EXPI -0.05
- ARQT 0.24
- Stochastic Oscillator
- EXPI 36.24
- ARQT 89.30
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.